The goal of this clinical trial is to learn what dose of ruxolitinib can be given safely together with retifanlimab in patients with metastatic renal cell carc…

Non Small Cell Lung CarcinomaRenal Cell Carcinoma

~Estimated

~$10 – $6,250

University of California, San DiegoNCT07219576

Biology of Young Lung Cancer Study: The YOUNG LUNG Study

The purpose of this research study is to learn more about lung cancer (NSCLC or SCLC) diagnosed in adults at ages 45 or younger.

Non Small Cell Lung CancerSmall Cell Lung CarcinomaNUT Carcinoma

~Estimated

~$10 – $1,125

Dana-Farber Cancer InstituteNCT05265429

Phase 2

A Phase 2 Study of PLK1 Inhibitor, Onvansertib, in Relapsed Small Cell Lung Cancer

This phase II clinical trial will study the safety and efficacy of onvansertib to treat patients with small cell lung cancer (SCLC) who have either not respond…

Small-cell Lung CancerSmall Cell Lung Carcinoma

~Estimated

~$10 – $6,250

University of Maryland, BaltimoreNCT05450965

← PreviousPage 3 of 3Next →